CIK 0001831828 · Large accelerated filer
Vera Therapeutics, Inc.
Sign in to watch- Ticker
- VERA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812744449
- Phone
- 650-770-0077
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,334,142
- in 2 filings, $1.3M under 10b5-1 plans
Net −$1,334,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 98 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-25 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +900 | $2.90 | $3K | 308,872 |
| 2024-09-25 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −900 | $46.79 | $42K | 307,972 |
| 2024-09-25 | Fordyce Marshall PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,625 | 811,712 | ||
| 2024-09-25 | Fordyce Marshall PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,875 | 809,837 | ||
| 2024-09-25 | Fordyce Marshall PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,875 | 807,962 | ||
| 2024-09-25 | Fordyce Marshall PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,875 | 806,087 | ||
| 2024-09-25 | Fordyce Marshall PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,875 | 804,212 | ||
| 2024-09-19 | SEIDENBERG BETH C Director | Sale 10b5-1 | −13,823 | $42.31 | $585K | 146,553 |
| 2024-09-18 | SEIDENBERG BETH C Director | Sale 10b5-1 | −1,177 | $42.01 | $49K | 160,376 |
| 2024-09-18 | SEIDENBERG BETH C Director | Sale 10b5-1 | −1,476 | $42.00 | $62K | 4,012 |
| 2024-09-11 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +9,274 | $2.90 | $27K | 317,246 |
| 2024-09-11 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −9,274 | $37.31 | $346K | 307,972 |
| 2024-09-11 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +6,351 | $2.90 | $18K | 314,323 |
| 2024-09-11 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −6,351 | $37.78 | $240K | 307,972 |
| 2024-09-11 | Fordyce Marshall PRESIDENT AND CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,625 | 827,337 | ||
| 2024-08-28 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +14,925 | $2.90 | $43K | 337,592 |
| 2024-08-28 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −14,925 | $36.80 | $549K | 322,667 |
| 2024-08-28 | Fordyce Marshall PRESIDENT AND CEO | Option exercise 10b5-1 | +700 | $2.90 | $2K | 323,367 |
| 2024-08-28 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −700 | $37.54 | $26K | 322,667 |
| 2024-08-28 | Fordyce Marshall PRESIDENT AND CEO | Sale 10b5-1 | −13,995 | $36.82 | $515K | 308,672 |
Page 12 of 17 · 321 trades